Assessment of the Turkish health care system reforms: A stakeholder analysis

Akinci, Fevzi; Mollahaliloğlu, Salih; Gürsöz, Hakkı; Ogucu, Fatma

doi:10.1016/j.healthpol.2012.05.002

Cited by 55 publications

(36 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As a result of these changes, some published reports highlight Turkey's improvements in terms of accessibility, affordability and quality of healthcare (Akinci et al . , Atun et al . ).…”

Section: Resultsmentioning

confidence: 99%

Patient companions in the Turkish healthcare system: the role, expectations and problems

Çelik

Hikmet

Şantaş

et al. 2017

Health Soc Care Community

View full text Add to dashboard Cite

The purpose of this study was to determine the roles, expectations and problems of patient companions and to develop solutions to the difficulties encountered by the nurses, patients and their companions. A qualitative approach with semi-structured face-to-face interviews was used during May and June 2014 to collect data. A convenience sample of participants was selected from the nurses, patients and their companions. Content analysis was used for the data. The results of this study revealed that the need for companions is important to the current Turkish healthcare system, but it has many drawbacks. As companions are witness to a patient's declining health and family, social and financial problems, their role should be to support their patients emotionally or socially, but they should not perform medical tasks. Therefore, the agencies responsible for managing the use of patient companions should regularly review its function by communicating often with the patients and their caregivers. Open communication between patient companions and all those responsible for patient care could improve the present difficulties which exist.

show abstract

“…As a result of these changes, some published reports highlight Turkey's improvements in terms of accessibility, affordability and quality of healthcare (Akinci et al . , Atun et al . ).…”

Section: Resultsmentioning

confidence: 99%

Patient companions in the Turkish healthcare system: the role, expectations and problems

Çelik

Hikmet

Şantaş

et al. 2017

Health Soc Care Community

View full text Add to dashboard Cite

show abstract

“…These publications aim to show the comparison of main health status indicators, which is the most remarkable achievement of the HTP, patient satisfaction and other input indicators (such as the number of health personnel per 1000, the level of investment etc.) [9,30,31,[50][51][52][53][54].…”

Section: Resultsmentioning

confidence: 99%

What have health care reforms achieved in Turkey? An appraisal of the “Health Transformation Programme”

Ökem

Çakar

2015

Health Policy

View full text Add to dashboard Cite

“…We divided stakeholders into six categories: pharmaceutical sector, public health, intellectual property law, government, non-governmental organizations (NGOs) and research funding organizations. We explored influence and power by questions focusing on the alliances and resources of the stakeholders [31–33]. Based on inductive interpretation of the interview, stakeholders’ power/influence was categorized for their sector, according to whether they had high or low influence on policy relating to access to medicines (e.g.…”

Section: Methodsmentioning

confidence: 99%

Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis

McMullan

Ajay

Srinivas

et al. 2018

Global Health Action

View full text Add to dashboard Cite

Background: In India, 50–65% of the population face difficulties in accessing medicines. The Health Impact Fund (HIF) is a novel proposal whereby pharmaceutical companies would be paid based on the measured global health impact of their drugs. We conducted a key stakeholder analysis to explore access to medicines in India, acceptability of the HIF and potential barriers and facilitators at policy level. Objectives: To conduct a stakeholder analysis of the HIF in India: to determine key stakeholder views regarding access to medicines in India; to evaluate acceptability of the HIF; and to assess potential barriers and facilitators to the HIF as a policy. Methods: In New Delhi, we conducted semi-structured interviews. There was purposive recruitment of participants with snowball sampling. Transcribed data were analysed using stakeholder analysis frameworks and directed content analysis. Results: Participation rate was 29% (14/49). 14 semi-structured interviews were conducted among stakeholders in New Delhi. All participants highlighted access to medicines as a problem in India. There were mixed views about the HIF in terms of relevance and scaleability. Stakeholders felt it should focus on diseases with limited or no market and potentially incorporate direct investment in research. Conclusions: First, access to medicines is perceived to be a major problem in India by all stakeholders, but affordability is just one factor. Second, stakeholders despite considerable support for the idea of the HIF, there are major concerns about scaleability, generalisability and impact on access to medicines. Third, the HIF and other novel drug-related health policies can afford to be more radical, e.g. working outside the existing intellectual property rights regime, targeting generic as well as branded drugs, or extending to research and development. Further innovations in access to medicines must involve country-specific key stakeholders in order to increase the likelihood of their success.

show abstract

Assessment of the Turkish health care system reforms: A stakeholder analysis

Cited by 55 publications

References 13 publications

Patient companions in the Turkish healthcare system: the role, expectations and problems

Patient companions in the Turkish healthcare system: the role, expectations and problems

What have health care reforms achieved in Turkey? An appraisal of the “Health Transformation Programme”

Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis

Contact Info

Product

Resources

About